Comparing the profile of gene changes between subjects with MDD and mice with genetically-altered Bdnf signaling suggest that the reduced somatostatin, neuropeptide Y and cortistatin are partly downstream from a combination of reduced constitutive and activity-dependent Bdnf signaling (Guilloux et al., 2012). This evidence concerns the gene BDNF and major depressive disorder.